PRESTA- Promoting Recovery after Stroke with Amantadine
Enrolling By Invitation
18-99 years
All
Phase
2
60 participants needed
1 Location
Brief description of study
The research team aims to examine whether amantadine can help patients recover from stroke. This will be a blinded randomized clinical trial. We will randomize patients post-ischemic or hemorrhagic stroke either to the placebo arm or amantadine. Patients will be on study drug or placebo for 1 month but will be enrolled for 3 months total. At various time points they will be examined and fill out questionnaires to determine their level of stroke recovery.
Adult subjects within 24 hours to 3 weeks after an ischemic or hemorrhagic stroke, will be recruited from Penn Medicine's Emergency Department, inpatient and outpatient practices by the Stroke team.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: stroke,cardiac
-
Age: Between 18 Years - 99 Years
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 849451
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
